BioProcess International at ChinaBio™ 2027

 

Description: As China’s biopharma innovation accelerates, the path from discovery to patient depends on manufacturing.

The BioProcess International track at ChinaBio™ puts bioprocessing, CMC, and manufacturing strategy at the center of the conversation, right alongside the R&D leaders whose breakthroughs depend on it.

With the discovery and clinical pioneers driving China’s next generation of therapies in the room, this is where the critical questions get answered: how to scale novel modalities from bench to commercial supply, how CDMOs and biopharma companies are reshaping partnership models, and how manufacturing innovation is becoming a true competitive differentiator rather than a downstream afterthought.

 

More Info

---

---